Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes.
Sockolosky JT, Trotta E, Parisi G, Picton L, Su LL, Le AC, Chhabra A, Silveria SL, George BM, King IC, Tiffany MR, Jude K, Sibener LV, Baker D, Shizuru JA, Ribas A, Bluestone JA, Garcia KC.
Sockolosky JT, et al. Among authors: trotta e.
Science. 2018 Mar 2;359(6379):1037-1042. doi: 10.1126/science.aar3246.
Science. 2018.
PMID: 29496879
Free PMC article.